miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer

Carcinogenesis

Volumn 35, Issue 1, 2014, Pages 173-183

  Zheng, Haoxuan ^a   Li, Wenjing ^a   Wang, Yadong ^a   Xie, Tingting ^a,b   Cai, Yidong ^a,c   Wang, Zhiqing ^a   Jiang, Bo ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c XIYUAN HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; UVOMORULIN;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTIGENS, CD95; CADHERINS; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FAS LIGAND PROTEIN; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MICE; MICE, INBRED BALB C; MICRORNAS; NFATC TRANSCRIPTION FACTORS; PRECANCEROUS CONDITIONS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 84891353803     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt274     Document Type: Article

References (46)

1. Curtin,J.F. et al. (2003) Live and let die: regulatory mechanisms in Fasmediated apoptosis. Cell. Signal., 15, 983-992.
2. Shinohara,H. et al. (2000) Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation. Cancer Res., 60, 1766-1772.
3. Park,D.R. et al. (2003) Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J. Immunol., 170, 6209-6216.
4. Choi,C. et al. (2001) Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Cancer Res., 61, 3084-3091.
5. Chen,L. et al. (2010) CD95 promotes tumour growth. Nature, 465, 492-496.
6. Barnhart,B.C. et al. (2004) CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J., 23, 3175-3185.
7. Zheng,H.X. et al. (2013) Fas signaling promotes motility and metastasis through epithelial-mesenchymal transition in gastrointestinal cancer. Oncogene, 32, 1183-1192.
8. Kalluri,R. (2009) EMT: when epithelial cells decide to become mesenchymal- like cells. J. Clin. Invest., 119, 1417-1419.
9. Lee,J.M. et al. (2006) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol., 172, 973-981.
10. Kalluri,R. et al. (2009) The basics of epithelial-mesenchymal transition. J. Clin. Invest., 119, 1420-1428.
11. Zheng,H. et al. (2013) Glycogen synthase kinase-3 beta regulates Snail and ß-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer. Eur. J. Cancer, 49, 2734-2746.
12. Croce,C.M. (2009) Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet., 10, 704-714.
13. Schetter,A.J. et al. (2009) Association of inflammation-related and micro- RNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin. Cancer Res., 15, 5878-5887.
14. Korpal,M. et al. (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem., 283, 14910-14914.
15. Park,S.M. et al. (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev., 22, 894-907.
16. Gregory,P.A. et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol., 10, 593-601.
17. Ma,L. et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol., 12, 247-256.
18. Liu,Y. et al. (2012) MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis. Med. Sci. Monit., 18, BR299-BR308.
19. Cao,M. et al. (2012) MiR-23a regulates TGF-ß-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells. Int. J. Oncol., 41, 869-875.
20. Chen,Z.L. et al. (2011) microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J. Biol. Chem., 286, 10725-10734.
21. Severson,E.A. et al. (2010) Glycogen Synthase Kinase 3 (GSK-3) influences epithelial barrier function by regulating occludin, claudin-1 and E-cadherin expression. Biochem. Biophys. Res. Commun., 397, 592-597.
22. Jahid,S. et al. (2012) miR-23a promotes the transition from indolent to invasive colorectal cancer. Cancer Discov., 2, 540-553.
23. Margariti,A. et al. (2010) Histone deacetylase 7 controls endothelial cell growth through modulation of beta-catenin. Circ. Res., 106, 1202-1211.
24. Lin,Z. et al. (2009) miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc. Natl Acad. Sci. USA, 106, 12103-12108.
25. Li,D. et al. (2013) The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis. Clin. Cancer Res., 19, 62-72.
26. Hogan,P.G. et al. (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev., 17, 2205-2232.
27. Gómez-Sintes,R. et al. (2010) NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy. J. Clin. Invest., 120, 2432-2445.
28. Grimes,C.A. et al. (2001) The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol., 65, 391-426.
29. Cavallaro,U. et al. (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer, 4, 118-132.
30. Huang,S. et al. (2008) Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int. J. Cancer, 123, 972-978.
31. Chhabra,R. et al. (2010) Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases. Mol. Cancer, 9, 232.
32. Chhabra,R. et al. (2009) Upregulation of miR-23a-27a-24-2 cluster induces caspase-dependent and -independent apoptosis in human embryonic kidney cells. PLoS One, 4, e5848.
33. Kong,K.Y. et al. (2010) MIR-23A microRNA cluster inhibits B-cell development. Exp. Hematol., 38, 629-640.e1.
34. Saarikangas,J. et al. (2011) Missing-in-metastasis MIM/MTSS1 promotes actin assembly at intercellular junctions and is required for integrity of kidney epithelia. J. Cell Sci., 124, 1245-1255.
35. Mancini,M. et al. (2009) NFAT proteins: emerging roles in cancer progression. Nat. Rev. Cancer, 9, 810-820.
36. Jauliac,S. et al. (2002) The role of NFAT transcription factors in integrinmediated carcinoma invasion. Nat. Cell Biol., 4, 540-544.
37. Medyouf,H. et al. (2007) Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nat. Med., 13, 736-741.
38. Ryeom,S. et al. (2008) Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell, 13, 420-431.
39. Sanna,B. et al. (2005) Direct and indirect interactions between calcineurin- NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Mol. Cell. Biol., 25, 865-878.
40. Eferl,R. et al. (2003) AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer, 3, 859-868.
41. Monje,P. et al. (2003) Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Mol. Cell. Biol., 23, 7030-7043.
42. Luo,J. (2009) Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett., 273, 194-200.
43. Boyle,W.J. et al. (1991) Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell, 64, 573-584.
44. Hedgepeth,C.M. et al. (1997) Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev. Biol., 185, 82-91.
45. Beals,C.R. et al. (1997) Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science, 275, 1930-1934.
46. Tang,H.L. et al. (2012) Expression and clinical significance of miR-23a and metastasis suppressor 1 in colon carcinoma. Zhonghua Bing Li Xue Za Zhi, 41, 28-32.